{"id":"W2131784126","doi":"10.1038/bjc.2015.343","title":"A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Eribulin; Neutropenia; Internal medicine; Cohort; Oncology; Chemotherapy; Metastatic breast cancer; Cancer; Gastroenterology; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005192562,0.001198556,0.001710963,0.0004903682,0.0005686997,0.0007536552,0.001000738,0.001246364,0.002346234],"category_scores_gemma":[0.001467692,0.0005714483,0.001339128,0.0007145855,0.0010925,0.0008312704,0.0005864042,0.002840163,0.0005911182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001488186,"about_ca_system_score_gemma":0.002553676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002127835,"about_ca_topic_score_gemma":0.004021009,"domain_scores_codex":[0.9986033,0.0008468616,0.00006063642,0.0001778146,0.0001719231,0.0001395369],"domain_scores_gemma":[0.9979969,0.0002788347,0.0003894144,0.0001907703,0.0001742582,0.0009698368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6093225,0.1137689,0.0330532,0.001070434,0.00381526,0.0006104299,0.001228838,0.003798365,0.05868541,0.0004661012,0.006947687,0.1672329],"study_design_scores_gemma":[0.421223,0.5195069,0.04808042,0.00003562531,0.0007256598,0.0004885721,0.0001082376,0.001065431,0.002969221,0.0001745103,0.005577041,0.00004539654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994727,0.00129213,0.0002877426,0.0006179568,0.00003124815,0.001524862,0.0003028954,0.00002775496,0.001188363],"genre_scores_gemma":[0.9873047,0.00229782,0.002303162,0.001518842,0.000173401,0.002839959,0.001579769,0.00002455122,0.001957877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005192562,"threshold_uncertainty_score":0.02746123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01715302010971483,"score_gpt":0.34147396194387,"score_spread":0.3243209418341552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}